Clinical Practice Status of Sentinel Lymph Node Biopsy for Early-Stage Breast Cancer Patients in China: A Multicenter Study

References

• Ecanow JS, Abe H, Newstead GM, Ecanow DB, Jeske JM. Axillary staging of breast cancer: what the radiologist should know. Radiographics. 2013;33(6):1589–1612. doi:10.1148/rg.33612506024108553
   PubMed Web of Science ®Google Scholar
• Manca G, Rubello D, Tardelli E, et al. Sentinel lymph node biopsy in breast cancer: indications, contraindications, and controversies. Clin Nucl Med. 2016;41(2):126–133. doi:10.1097/RLU.000000000000098526447368
   PubMed Web of Science ®Google Scholar
• Jatoi I, Benson JR, Toi M. De-escalation of axillary surgery in early breast cancer. Lancet Oncol. 2016;17(10):e430–e441. doi:10.1016/S1470-2045(16)30311-427733269
   PubMed Web of Science ®Google Scholar
• Charalampoudis P, Markopoulos C, Kovacs T. Controversies and recommendations regarding sentinel lymph node biopsy in primary breast cancer: a comprehensive review of current data. Eur J Surg Oncol. 2018;44(1):5–14. doi:10.1016/j.ejso.2017.10.21529174281
   PubMed Web of Science ®Google Scholar
• Manca G, Tardelli E, Rubello D, et al. Sentinel lymph node biopsy in breast cancer: a technical and clinical appraisal. Nucl Med Commun. 2016;37(6):570–576. doi:10.1097/MNM.000000000000048926886421
   PubMed Web of Science ®Google Scholar
• Niebling MG, Pleijhuis RG, Bastiaannet E, Brouwers AH, van Dam GM, Hoekstra HJ. A systematic review and meta-analyses of sentinel lymph node identification in breast cancer and melanoma, a plea for tracer mapping. Eur J Surg Oncol. 2016;42(4):466–473. doi:10.1016/j.ejso.2015.12.00726853759
   PubMed Web of Science ®Google Scholar
• Zengel B, Yararbas U, Sirinocak A, et al. Sentinel lymph node biopsy in breast cancer: review on various methodological approaches. Tumori. 2013;99(2):149–153. doi:10.1177/03008916130990020523748806
   PubMed Web of Science ®Google Scholar
• Li J, Chen X, Qi M, Li Y, Metze K. Sentinel lymph node biopsy mapped with methylene blue dye alone in patients with breast cancer: a systematic review and meta-analysis. PLoS One. 2018;13(9):e0204364. doi:10.1371/journal.pone.020436430235340
   PubMed Web of Science ®Google Scholar
• Sugie T, Ikeda T, Kawaguchi A, Shimizu A, Toi M. Sentinel lymph node biopsy using indocyanine green fluorescence in early-stage breast cancer: a meta-analysis. Int J Clin Oncol. 2017;22(1):11–17. doi:10.1007/s10147-016-1064-z27864624
   PubMed Web of Science ®Google Scholar
• Guo J, Yang H, Wang S, et al. Comparison of sentinel lymph node biopsy guided by indocyanine green, blue dye, and their combination in breast cancer patients: a prospective cohort study. World J Surg Oncol. 2017;15(1):196. doi:10.1186/s12957-017-1264-729096643
   PubMed Web of Science ®Google Scholar
• Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial. JAMA. 2017;318(10):918–926. doi:10.1001/jama.2017.1147028898379
   PubMed Web of Science ®Google Scholar
• Kuehn T, Bauerfeind I, Fehm T, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013;14(7):609–618. doi:10.1016/S1470-2045(13)70166-923683750
   PubMed Web of Science ®Google Scholar
• Canavese G, Bruzzi P, Catturich A, et al. Sentinel lymph node biopsy versus axillary dissection in node-negative early-stage breast cancer: 15-year follow-up update of a randomized clinical trial. Ann Surg Ancol. 2016;23(8):2494–2500.
   Web of Science ®Google Scholar
• Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised Phase 3 trial. Lancet Oncol. 2010;11(10):927–933. doi:10.1016/S1470-2045(10)70207-220863759
   PubMed Web of Science ®Google Scholar
• Wiatrek R, Kruper L. Sentinel lymph node biopsy indications and controversies in breast cancer. Maturitas. 2011;69(1):7–10. doi:10.1016/j.maturitas.2011.02.00621411254
   PubMed Web of Science ®Google Scholar
• Rescigno J, Zampell JC, Axelrod D. Patterns of axillary surgical care for breast cancer in the era of sentinel lymph node biopsy. Ann Surg Oncol. 2009;16(3):687–696. doi:10.1245/s10434-008-0195-519101768
   PubMed Web of Science ®Google Scholar
• Poodt IGM, Spronk PER, Vugts G, et al. Trends on axillary surgery in nondistant metastatic breast cancer patients treated between 2011 and 2015: a Dutch population-based study in the ACOSOG-Z0011 and AMAROS era. Ann Surg. 2018;268(6):1084–1090. doi:10.1097/SLA.000000000000244028742702
   PubMed Web of Science ®Google Scholar
• Mann JM, Wu X, Christos P, Nagar H. The state of surgical axillary management and adjuvant radiotherapy for early-stage invasive breast cancer in the modern era. Clin Breast Cancer. 2018;18(4):e477–e493. doi:10.1016/j.clbc.2017.09.00129031423
   PubMed Web of Science ®Google Scholar
• Leong SP, Shen ZZ, Liu TJ, et al. Is breast cancer the same disease in Asian and Western countries? World J Surg. 2010;34(10):2308–2324. doi:10.1007/s00268-010-0683-120607258
   PubMed Web of Science ®Google Scholar
• Cody HS. Clinical aspects of sentinel node biopsy. Breast Cancer Res. 2001;3(2):104–108. doi:10.1186/bcr28011250755
   PubMed Web of Science ®Google Scholar
• Yuan L, Qi X, Zhang Y, et al. Comparison of sentinel lymph node detection performances using blue dye in conjunction with indocyanine green or radioisotope in breast cancer patients: a prospective single-center randomized study. Cancer Biol Med. 2018;15(4):452–460. doi:10.20892/j.issn.2095-3941.2018.027030766755
   PubMed Web of Science ®Google Scholar
• Park S, Koo JS, Kim GM, et al. Feasibility of charcoal tattooing of cytology-proven metastatic axillary lymph node at diagnosis and sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients. Cancer Res Treat. 2018;50(3):801–812. doi:10.4143/crt.2017.21028814071
   PubMed Web of Science ®Google Scholar
• Zada A, Peek MC, Ahmed M, et al. Meta-analysis of sentinel lymph node biopsy in breast cancer using the magnetic technique. Br J Surg. 2016;103(11):1409–1419. doi:10.1002/bjs.1028327611729
   PubMed Web of Science ®Google Scholar
• Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569–575. doi:10.1001/jama.2011.9021304082
   PubMed Web of Science ®Google Scholar
• Robinson KA, Pockaj BA, Wasif N, Kaufman K, Gray RJ. Have the American College of Surgeons Oncology Group Z0011 trial results influenced the number of lymph nodes removed during sentinel lymph node dissection? Am J Surg. 2014;208(6):1060–1064; discussion 1063–1064. doi:10.1016/j.amjsurg.2014.08.009
   Web of Science ®Google Scholar
• Imoto S, Yamauchi C, Komoike Y, et al. Trends in axillary treatment for breast cancer patients undergoing sentinel lymph node biopsy as determined by a questionnaire from the Japanese Breast Cancer Society. Breast Cancer (Tokyo, Japan). 2017;24(3):427–432. doi:10.1007/s12282-016-0721-4
   Web of Science ®Google Scholar
• Duraes M, Guillot E, Seror J, Pouget N, Rouzier R. [Sentinel lymph node biopsy and neoadjuvant treatment in breast cancer]. Bull Cancer. 2017;104(10):892–901. doi:10.1016/j.bulcan.2017.08.003. French.28890124
   PubMed Web of Science ®Google Scholar
• Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol. 1997;15(7):2483–2493. doi:10.1200/JCO.1997.15.7.24839215816
   PubMed Web of Science ®Google Scholar
• Boughey JC, Suman VJ, Mittendorf EA, et al. Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance). Ann Surg. 2015;261(3):547–552. doi:10.1097/SLA.000000000000055125664534
   PubMed Web of Science ®Google Scholar
• Tee SR, Devane LA, Evoy D, et al. Meta-analysis of sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with initial biopsy-proven node-positive breast cancer. Br J Surg. 2018;105(12):1541–1552. doi:10.1002/bjs.1098630311642
   PubMed Web of Science ®Google Scholar